Sara Fancelli Enrico Caliman Francesca Mazzoni Luca Paglialunga Marta Rita Gatta Michelet Daniele Lavacchi Rossana Berardi Giulia Mentrasti Giulio Metro Ilaria Birocchi Angelo Delmonte Ilaria Priano Camilla Eva Comin Francesca Castiglione Caterina Bartoli Luca Voltolini Serena Pillozzi Lorenzo Antonuzzo
10.3389/fonc.2022.968064
Front Oncol
2022 Nov 14;12:968064.
kras g12 isoforms kras mutations pd-l1 immune check-point inhibitors treatment responses
CC BY
https://pubmed.ncbi.nlm.nih.gov/36452502/
PMC9702560
36452502
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population
2022